Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists

By Cook David  

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 15-21

Springer Publishing Company

Access to resources Recommend Favorite

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas

By Vallette Sophie   Serri Karim   Rivera Juan   Santagata Patricia   Delorme Sophie   Garfield Natasha   Kahtani Nora   Beauregard Hugues   Aris-Jilwan Nahla   Houde Ghislaine   Serri Omar  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 153-157

Springer Publishing Company

Access to resources Recommend Favorite

Clinical profile and long term follow up of children and adolescents with prolactinomas

By Acharya Shrikrishna   Gopal Raju   Bandgar Tushar   Joshi Shashank   Menon Padma   Shah Nalini  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 186-189

Springer Publishing Company

Access to resources Recommend Favorite

Tolerability and Efficacy of Almotriptan in the Long-Term Treatment of Migraine

By  

European Neurology, Vol. 45, Iss. 4, 2001-05 ,pp. : 206-213

Karger

Access to resources Recommend Favorite

Combined Treatment of Invasive Giant Prolactinomas

By Yu Chonjiang   Wu Zhebao   Gong Jian  

Pituitary, Vol. 8, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite